1. Home
  2. JOUT vs FULC Comparison

JOUT vs FULC Comparison

Compare JOUT & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$42.76

Market Cap

400.6M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$13.80

Market Cap

468.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
FULC
Founded
1970
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.6M
468.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JOUT
FULC
Price
$42.76
$13.80
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$15.88
AVG Volume (30 Days)
38.9K
2.4M
Earning Date
12-12-2025
10-29-2025
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,527,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2752.05
52 Week Low
$21.33
$2.32
52 Week High
$44.44
$15.74

Technical Indicators

Market Signals
Indicator
JOUT
FULC
Relative Strength Index (RSI) 65.86 67.25
Support Level $40.56 $12.07
Resistance Level $41.49 $15.74
Average True Range (ATR) 1.49 1.24
MACD 0.39 0.36
Stochastic Oscillator 90.29 72.72

Price Performance

Historical Comparison
JOUT
FULC

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: